how many americans are on glp-1 medications U.S. Obesity Rate Drops As Usage Grows America's Most Talked-About Drug Has

Liraglutide protects non-alcoholic fatty liver disease via inhibiting NLRP3 inflammasome activation in a mouse model induced by high-fat diet

Diabetologia 55 , 33083317 (2012)

Primary Eye Health Concerns Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) The most significant concern emerging from recent research is the potential increased risk of NAION, a vision-threatening condition that affects the optic nerve

Alternatively, a hydroxyapatite toothpaste like Boka or RiseWell provides remineralization support without requiring fluoride, though fluoride remains the most evidence-backed option for cavity prevention

The choice, when both are options, depends on your health profile, how you respond to medication, cost considerations, and your clinician's judgment

A translational study of 21 patients with type 2 diabetes and obesity found that six months of semaglutide treatment changed what their epicardial fat tissue secreted